Roy Lester Freeman - Feb 14, 2025 Form 4 Insider Report for Inhibikase Therapeutics, Inc. (IKT)

Role
Director
Signature
/s/ Garth Lees-Rolfe, attorney-in-fact
Stock symbol
IKT
Transactions as of
Feb 14, 2025
Transactions value $
$0
Form type
4
Date filed
2/19/2025, 08:16 PM
Previous filing
Jan 22, 2025

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IKT Stock Option (Right to Buy) Award $0 +22.6K $0.00 22.6K Feb 14, 2025 Common Stock 22.6K $2.35 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vested and became exercisable on February 14, 2025.

Remarks:

Exhibit 24 - Power of Attorney